Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
18 Years
N/A
Both
Hepatitis, Hepatocellular Carcinomas
Trial Information
Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
Patients will be exposed by different specific amplitude-modulated frequencies of low
intensity electromagnetic fields for 30 min. During the exposure, autonomic response with be
recorded in order to identify biofeedback response. Differences in group of frequencies is
expected in patients with hepatitis B carries with or without hepatocellular carcinoma.
Inclusion Criteria:
- hepatitis B carriers patients
- hepatitis B carriers patients with hepatocellular cancer patients
Exclusion Criteria:
- other tumor types
- other hepatitis types
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic
Outcome Measure:
Identification of different group of specific frequencies of modulation in hepatitis B carriers with and without hepatocellular carcinoma associated with biofeedback response
Outcome Description:
biofeedback response will be monitored
Outcome Time Frame:
within 10 min of exposure
Safety Issue:
Yes
Principal Investigator
Frederico P Costa, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Hospital Sirio-Libanes
Authority:
Brazil: National Committee of Ethics in Research
Study ID:
02621512.3.0000.5461
NCT ID:
NCT01641276
Start Date:
April 2012
Completion Date:
June 2013
Related Keywords:
- Hepatitis
- Hepatocellular Carcinomas
- biofeedback response
- Carcinoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Carcinoma, Hepatocellular
Name | Location |
|---|
